James W. Barr

James W. Barr

Auto-generated profile, based on publicly available information

James W. Barr

BluePearl Veterinary Partners, LLC Spring, Texas 77388 USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
Romy M. HeilmannRomy M. Heilmann
Romy M. Heilmann
AJAlbert E. Jergens
Albert E. Jergens
MAMark R. Ackermann
Mark R. Ackermann
JBJames W. Barr
James W. Barr
Jan SuchodolskiJan Suchodolski
Jan Suchodolski
JSJörg M. Steiner
Jörg M. Steiner
Objective—To measure serum calprotectin concentration in dogs with inflammatory bowel disease (IBD) before and after initiation of treatment and evaluate its correlation with a clinical scoring system (canine IBD activity index), serum canine C-reactive protein concentration, and severity of histopathologic changes. Animals—34 dogs with idiopathic IBD and 139 healthy control dogs. Procedures—From dogs with IBD, blood samples were collected immediately before (baseline) and 3 weeks after initiation of 1 of 2 treatments: prednisone (1 mg/kg, PO, q 12 h; n = 21) or a combination of prednisone and metronidazole (10 mg/kg, PO, q 12 h; 13). Blood samples were collected once from each of the control dogs. For all samples, serum calprotectin concentration was determined via radioimmunoassay. Results—Mean serum calprotectin concentrations for dogs with IBD at baseline (431.1 μg/L) and 3 weeks after initiation of treatment (676.9 μg/L) were significantly higher, compared with that (219.4 μg/L) for control dogs, and were not significantly correlated with the canine IBD activity index, serum C-reactive protein concentration, or severity of histopathologic changes. The use of a serum calprotectin concentration of ≥ 296.0 μg/L as a cutoff had a sensitivity of 82.4% (95% confidence interval, 65.5% to 93.2%) and specificity of 68.4% (95% confidence interval, 59.9% to 76.0%) for distinguishing dogs with idiopathic IBD from healthy dogs. Conclusions and Clinical Relevance—Serum calprotectin concentration may be a useful biomarker for the detection of inflammation in dogs, but the use of certain drugs (eg, glucocorticoids) appears to limit its clinical usefulness.

3 April 2014 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
MPMedora B. Pashmakova
Medora B. Pashmakova
MBMicah A. Bishop
Micah A. Bishop
JSJörg M. Steiner
Jörg M. Steiner
Jan SuchodolskiJan Suchodolski
Jan Suchodolski
JBJames W. Barr
James W. Barr

1 May 2012 in Topics in Companion Animal Medicine
Verified
Journal Article
Closed access
JBJames W. Barr
James W. Barr
MMMaureen McMichael
Maureen McMichael

1 November 2011 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Closed access
PDF file
ACA.K. Cook
A.K. Cook
AAA.K. Allen
A.K. Allen
DED. Espinosa
D. Espinosa
JBJ. Barr
J. Barr

20 January 2015 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
NPNathan W. Peterson
Nathan W. Peterson
NBNicole J. Buote
Nicole J. Buote
JBJames W. Barr
James W. Barr

25 July 2017 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
CWC. R. Wilson
C. R. Wilson
MPM. B. Pashmakova
M. B. Pashmakova
JHJ. A. Heinz
J. A. Heinz
MJM. C. Johnson
M. C. Johnson
HMH. M. Minard
H. M. Minard
JBJ. W. Barr
J. W. Barr